Incyte (INCY) Research & Development (2009 - 2026)
Incyte (INCY) reported Research & Development of $1.79 billion for Q3 2026, up 253.7% from $506.58 million a year earlier and up 246.6% from the prior quarter.
Powered by 
Analysis
Incyte (INCY) Research & Development (2009 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, Incyte's Research & Development came in at $3.44 billion, up 80.4% year-over-year; for FY2025, it came in at $2.05 billion, down 21.4% from FY2024.
- Research & Development has a five-year compound annual growth rate of -1.5% (FY2020 to FY2025).
- By year, Research & Development came in at $2.61 billion in FY2024 (+60.2%), $1.63 billion in FY2023 (+2.6%), $1.59 billion in FY2022 (+8.8%) and $1.46 billion in FY2021 (-34.2%).
- The Q3 2026 figure ranks as the highest quarterly Research & Development in data going back to Q1 2010.
- Year over year, Research & Development has now increased in each of the last four quarters, with growth averaging 30.7% over the last eight quarters.
- The high point for year-over-year Research & Development in five years was Q3 2026 (growth of 253.7%); the low point was Q2 2025 (a decline of 56.5%).
- Per Business Quant data, the three quarters before Q3 2026 came in at $516.95 million (Q2 2026), $515.9 million (Q1 2026) and $611.37 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.25 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 2.57 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 4.54 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 3.89 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 2.11 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.61 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 3.02 Bn |
| 10 | Incyte | 245.42 Mn | -15.74 Bn | 1.45 Bn | 1.79 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.79 Bn |
| Jun 30, 2026 | 516.95 Mn |
| Mar 31, 2026 | 515.90 Mn |
| Dec 31, 2025 | 611.37 Mn |
| Sep 30, 2025 | 506.58 Mn |
| Jun 30, 2025 | 494.92 Mn |
| Mar 31, 2025 | 437.28 Mn |
| Dec 31, 2024 | 466.03 Mn |
| Sep 30, 2024 | 573.17 Mn |
| Jun 30, 2024 | 1.14 Bn |
| Mar 31, 2024 | 429.26 Mn |
| Dec 31, 2023 | 444.49 Mn |
| Sep 30, 2023 | 375.71 Mn |
| Jun 30, 2023 | 400.75 Mn |
| Mar 31, 2023 | 406.64 Mn |
| Dec 31, 2022 | 501.36 Mn |
| Sep 30, 2022 | 384.01 Mn |
| Jun 30, 2022 | 347.20 Mn |
| Mar 31, 2022 | 353.37 Mn |
| Dec 31, 2021 | 472.83 Mn |
API Access
Incyte Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=INCY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "INCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=INCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();